Screener
Pacific Biosciences of California PACB Business Segments — Loss on Debt Extinguishment
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: Pacific Biosciences of California’s 10-K, filed February 25, 2026.
- Filed
- Feb 25, 2026, 4:03 PM EST
- Fiscal year
- FY2025
- Accession
- 0001299130-26-000034
| (In thousands) | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Merger-related expenses | — | — | 9,042 |
| Change in fair value of contingent consideration | (18,700) | (850) | 15,060 |
| Amortization of acquired intangible assets | 364,541 | 18,006 | 6,157 |
| Loss on extinguishment of debt | — | — | 2,033 |
| Gain on debt restructuring | — | (154,407) | — |
| Other income, net | 7,803 | 10,371 | 18,341 |
| Income tax provision (benefit) | 318 | 316 | (11,424) |
| Consolidated net loss | (546,376) | (309,851) | (306,735) |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Pacific Biosciences of California's business segments — loss on debt extinguishment?
- Pacific Biosciences of California (PACB) reported business segments — loss on debt extinguishment of $0 in Q4 2025.
- What does business segments — loss on debt extinguishment mean?
- This represents the financial loss recognized when the reportable segment retires debt obligations before their scheduled maturity date, typically involving a premium paid to creditors. It reflects the cost of restructuring capital or refinancing debt to optimize the balance sheet. Investors monitor this to understand the impact of debt management decisions on the segment's financial results.
Ask your AI about Pacific Biosciences of California's business segments — loss on debt extinguishment.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude